Non small cell lung cancer medical therapy metastatic cancer: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Non small cell lung cancer}} {{CMG}}; {{AE}} {{Alonso}} ==Overview== ==Medical Therapy for Metastatic Non-Small Cell Lung Cancer== Category:Disease ...") |
|||
Line 8: | Line 8: | ||
==Medical Therapy for Metastatic Non-Small Cell Lung Cancer== | ==Medical Therapy for Metastatic Non-Small Cell Lung Cancer== | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | A01 | | | | | A01=What the specific subtype according to the specific histological characteristics of the [[tumor]]?}} | |||
{{familytree | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | |}} | |||
{{familytree | | | | | B01 | | | | | | | | B02 | | | B01=<div style="float: left; text-align: left; width: 14em; padding:1em;"> | |||
* [[Adenocarcinoma]]<br> | |||
* [[Large cell carcinoma of the lung]]<br> | |||
* Not specified non-small cell lung cancer</div>|B02=[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]]}} | |||
{{familytree | | | | | |!| | | | | | | | | |!| | | }} | |||
{{familytree | | | | | C01 | | | | | | | | C02 | | | C01=Perform specific [[EGFR]] and ALK [[mutation]] testing: What is the specific [[mutation]]?|C02=Is the patient a smoker or former smoker?}} | |||
{{familytree | |,|-|-|-|+|-|-|-|.| | | | | |!| | |}} | |||
{{familytree | D01 | | D02 | | D03 | | | | D04 | | | D01=Sensitizing [[EGFR]] mutation|D02=ALK mutation|D03=Negative [[EGFR]] and ALK|D04=[[Non small cell carcinoma of the lung medical therapy#Metastatic squamous cell carcinoma|Click here for the squamous cell carcinoma specific treatment]]}} | |||
{{familytree | |!| | | |!| | | |!| | | | |}} | |||
{{familytree | E01 | | E02 | | E03 | | | E01=[[Non small cell carcinoma of the lung medical therapy#Positive sensitizing EGFR mutation|Click here for the sensitizing EGFR mutation specific treatment]]|E02=[[Non small cell carcinoma of the lung medical therapy#Positive ALK mutation|Click here for the specific therapy for the ALK mutation specific treatment]]|E03=[[Non small cell carcinoma of the lung medical therapy#Negative EGRF and ALK or unknown mutation|Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease]]}} | |||
{{familytree/end}} | |||
<br> | |||
Revision as of 13:48, 24 June 2014
Non Small Cell Lung Cancer Microchapters |
Differentiating Non Small Cell Lung Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non small cell lung cancer medical therapy metastatic cancer On the Web |
American Roentgen Ray Society Images of Non small cell lung cancer medical therapy metastatic cancer |
FDA on Non small cell lung cancer medical therapy metastatic cancer |
CDC on Non small cell lung cancer medical therapy metastatic cancer |
Non small cell lung cancer medical therapy metastatic cancer in the news |
Blogs on Non small cell lung cancer medical therapy metastatic cancer |
Directions to Hospitals Treating Non small cell carcinoma of the lung |
Risk calculators and risk factors for Non small cell lung cancer medical therapy metastatic cancer |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]
Overview
Medical Therapy for Metastatic Non-Small Cell Lung Cancer
What the specific subtype according to the specific histological characteristics of the tumor? | |||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | ||||||||||||||||||||||||||||||||||||||
Perform specific EGFR and ALK mutation testing: What is the specific mutation? | Is the patient a smoker or former smoker? | ||||||||||||||||||||||||||||||||||||||
Sensitizing EGFR mutation | ALK mutation | Negative EGFR and ALK | Click here for the squamous cell carcinoma specific treatment | ||||||||||||||||||||||||||||||||||||
Click here for the sensitizing EGFR mutation specific treatment | Click here for the specific therapy for the ALK mutation specific treatment | Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease | |||||||||||||||||||||||||||||||||||||